国产精品亚洲а∨天堂免在线,草榴2019,性生交大片免费动作,美女做爱免费视频,超碰在线进入,办公室女职员交换性bd,天天综合天天综合,久久大

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>

產(chǎn)品基本信息

產(chǎn)品編號：K200603

產(chǎn)品名稱：Keto Pioglitazone-d4 (M-III)

產(chǎn)品CAS：1215370-26-5

規(guī)格含量：5mg

產(chǎn)品價格：面議

聯(lián)系我們:

產(chǎn)品詳細介紹

標準品編號:	K200603
名稱:	Keto Pioglitazone-d4 (M-III)
別名:	5-[[4-[2-(5-Acetyl-2-pyridinyl)ethoxy]phenyl-d4]methyl]-2,4-thiazolidinedione; Keto-Pioglitazone (M-III)-d4;
CAS號:	1215370-26-5
參考CAS號:	146062-45-5
分子式:	C??H??D?N?O?S
外觀:	白色固體
熔點:	>62°C (dec.)
分子量:	374.45
儲存:	Hygroscopic, -20°C Freezer, Under inert atmosphere
溶解度:	Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
種類:	Building Blocks; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:	Keto Pioglitazone-d4 (M-III) is the labeled analogue of Keto Pioglitazone (M-III) (K200600), a metabolite of Pioglitazone (P471000), which is used as an antidiabetic.
參考文獻	Tanis, S.P., et al.: J. Med. Chem., 39, 5053 (1999); Hofmann, C., et al.: Endocrinology, 129, 1915(1991); Kobayashi, M., et al.: Diabetes, 41, 476 (1992); Kawaamori, R., et al.,: Diabetes Res. Clin. Pract., 41, 35 (1998)

聯(lián)系我們

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>